Turns donkey hides into ejiao, a gelatin defined by Chinese medicine law that no other animal can produce.
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 0
- ScaleMarket cap is above the global median
Turns donkey hides into ejiao, a gelatin defined by Chinese medicine law that no other animal can produce.
Dong-E-E-Jiao takes donkey hides through a precise alkalinization and temperature-controlled extraction process until the resulting gelatin crosses the amino acid threshold that China's NMPA pharmacopoeia uses to legally define ejiao — a threshold no other animal hide can reach, so substituting cattle or synthetic collagen does not produce cheaper ejiao, it produces a product that cannot be called ejiao at all. Because the specification locks in donkey hide as the only valid input, the real limit on how much ejiao the company can produce is not factory capacity but how many donkey hides exist globally, and donkeys breed slowly enough that supply cannot respond to rising demand within any single planning cycle. African suppliers currently provide the only meaningful room to expand that supply, but conservation pressure in those countries is already tightening exports, and if those restrictions harden into formal bans, the raw material ceiling falls below what current demand requires — and no amount of process refinement or additional extraction lines can compensate for hides that simply are not available.
How does this company make money?
The company sells ejiao blocks and ejiao powder by the unit. Those products move through Traditional Chinese Medicine distributors, health supplement retailers, and direct-to-consumer channels. Because ejiao carries traditional medicine status and supply is genuinely constrained, prices sit well above what ordinary gelatin commands.
What makes this company hard to replace?
Traditional Chinese Medicine practitioners need ejiao that meets specific pharmacopoeia standards for their blood-nourishment formulations, and requalifying a different supplier's product takes months. Chinese consumers also connect ejiao's perceived effectiveness to established brand names built up over years within Traditional Chinese Medicine — a reputation that a new entrant cannot simply buy or replicate quickly.
What limits this company?
Donkeys take roughly three years from birth to the point where their hides are usable, so hide supply cannot grow quickly even when demand rises. African imports are the only near-term way to add volume, and those are already being squeezed by conservation restrictions in the countries that export them. No matter how many extraction lines a producer installs, total output is capped by how many hides it can actually receive.
What does this company depend on?
The company cannot run without donkey hides from domestic Chinese farms and African importers, NMPA pharmaceutical manufacturing licenses that authorize ejiao production, Traditional Chinese Medicine quality standards certification, specialized gelatin extraction equipment built for donkey hide processing, and cold chain distribution networks that keep temperature-sensitive ejiao products stable in transit.
Who depends on this company?
Traditional Chinese Medicine practitioners rely on ejiao to fill blood-nourishment prescriptions; if supply dried up, they would have to requalify substitute formulations, which takes time. Chinese health supplement retailers carry ejiao as a product category, and a supply gap would leave their shelves short. Export distributors who supply overseas Chinese communities with traditional medicine products would find their ejiao offerings incomplete.
How does this company scale?
The production side — block forming, packaging, and running additional extraction lines — can be automated and replicated as demand grows. The supply side cannot keep up in the same way. Donkey breeding cycles, a limited global donkey population, and uncertain access to African hide suppliers all resist rapid expansion, so procurement remains the bottleneck no matter how efficiently the factory floor runs.
What external forces can significantly affect this company?
The most immediate external pressure is African governments restricting or banning donkey hide exports to protect their own donkey populations. On top of that, CITES wildlife trade regulations can affect how hides move across borders internationally. Inside China, government-led modernization requirements for the Traditional Chinese Medicine industry can impose new compliance standards that change how ejiao must be produced or documented.
Where is this company structurally vulnerable?
If African governments turn their current conservation pressure into formal, enforced bans on donkey hide exports, the incremental supply that keeps production tracking demand disappears overnight. China's domestic donkey population is too small to fill that gap within any breeding cycle that matters for near-term output, and the pharmacopoeia blocks any non-donkey substitute — so all the process expertise in the world becomes useless when the one input it requires cannot be sourced.
Sign in to view price data.
Sign inScreen for dividend patterns
Find other stocks with similar dividend characteristics in the screener.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.
CompanyGraph